Shareholders' Equity	3 Months Ended
Mar. 31, 2024
Equity [Abstract]
Shareholders' Equity	Note 8: Shareholders’ Equity In January 2024, the Company entered into an Open Market Sale AgreementSM (“Sales Agreement”) with Jefferies LLC as the sales agent, pursuant to which the Company may offer and sell, from time to time, through Jefferies, shares of its Class A ordinary shares, par value $0.0001 per share, having an aggregate offering price of up to $100.0 million by any method deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act (the “ATM Offering”). The shares are offered and sold pursuant to the Company’s shelf registration statement on Form S-3. During the three months ended March 31, 2024 and 2023, the Company did not sell any shares under the Sales Agreement. However, subsequent to March 31, 2024, the Company sold 2,301,900 of its Class A ordinary shares under the Sales Agreement for net proceeds of $3,238,000.

Shareholders' Equity

3 Months Ended

Mar. 31, 2024

Note 8: Shareholders’ Equity

In January 2024, the Company entered into an Open Market Sale AgreementSM (“Sales Agreement”) with Jefferies LLC as the sales agent, pursuant to which the Company may offer and sell, from time to time, through Jefferies, shares of its Class A ordinary shares, par value $0.0001 per share, having an aggregate offering price of up to $100.0 million by any method deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act (the “ATM Offering”). The shares are offered and sold pursuant to the Company’s shelf registration statement on Form S-3.

During the three months ended March 31, 2024 and 2023, the Company did not sell any shares under the Sales Agreement. However, subsequent to March 31, 2024, the Company sold 2,301,900 of its Class A ordinary shares under the Sales Agreement for net proceeds of $3,238,000.